F-Secure Oyj
5.3.2021 15:02:08 CET | Globenewswire | Press release
F-Secure Corporation, Stock Exchange Release, 5 March 2021, at 16.00 EET
F-Secure Corporation – Manager’s Transactions – Eriikka Söderström
F-Secure Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Söderström, Eriikka
Position: Chief Financial Officer
Issuer: F-Secure Oyj
LEI: 743700ATXLT0MFCHXT16
Notification type: INITIAL NOTIFICATION
Reference number: 743700ATXLT0MFCHXT16_20210226145530_2
____________________________________________
Transaction date: 2021-03-03
Venue not applicable
Instrument type: SHARE
ISIN: FI0009801310
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATION
Transaction details
(1): Volume: 4,050 Unit price: EUR
Aggregated transactions
(1): Volume: 4,050 Volume weighted average price: EUR
Contact information:
Henri Kiili, Investor Relations and Corporate Finance Director, F-Secure Corporation
+358 40 840 5450
investor-relations@f-secure.com
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Leading Edge Materials Corp.18.9.2026 20:30:00 CEST | Press release
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO JULY 31, 2026 AND ANNOUNCES CLOSING OF THE SECOND TRANCHE OF PRIVATE PLACEMENT
Orion Oyj18.9.2026 18:00:00 CEST | Press release
Orion Corporation: Acquisition of own shares during week 38, 2026
Marimekko Corporation18.9.2026 17:45:00 CEST | Press release
Marimekko Corporation: Repurchase of own shares during week 38/2026
Ress Life Investments A/S18.9.2026 16:53:29 CEST | Press release
Ress Life Investments A/S publishes Half-Year Report 1 January 2026 – 30 June 2026
Novartis Pharma AG18.9.2026 16:51:38 CEST | Press release
Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
